Usefulness of urine dipstick test in the management of adverse events associated with immune checkpoint inhibitors

被引:0
|
作者
Izumi, Keishiro [1 ]
Iyoda, Tomokazu [1 ,2 ]
Yokota, Atsuko [3 ]
Kanno, Masahito [2 ]
Hoshi, Masahiro [2 ]
Tokuda, Emi [4 ]
Sasaki, Eisaku [4 ]
Kanazawa, Kenya [1 ]
Kuroda, Junko [2 ]
Saji, Shigehira [1 ,4 ]
机构
[1] Fukushima Med Univ Hosp, Clin Oncol Ctr, 1 Hikarigaoka, Fukushima, Fukushima, Japan
[2] Fukushima Med Univ Hosp, Dept Pharm, 1 Hikarigaoka, Fukushima, Fukushima, Japan
[3] Tochigi Canc Ctr, Dept Pharm, 4-9-13 Yonan, Utsunomiya, Tochigi, Japan
[4] Fukushima Med Univ, Dept Med Oncol, 1 Hikarigaoka, Fukushima, Fukushima, Japan
关键词
Immune checkpoint inhibitor; Urine dipstick test; Patient's diary; Telephone follow-up; Pharmacist; THERAPY MANAGEMENT; URINALYSIS; DIARY;
D O I
10.1007/s00520-024-08928-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThe usefulness of urine dipstick tests (UDTs) in patients with diabetes has been reported. The aim of the present study was to investigate the utility of self-performed UDTs and patient diaries in the management of impaired glucose tolerance, one of the adverse events of immune checkpoint inhibitors (ICIs).MethodsPatients receiving ICIs underwent self-checks with UDTs twice a week for up to 6 months. Pharmacists checked the results at every patient visit, and by phone every 3 months. The primary endpoint was to prospectively assess whether symptoms recorded in patient diaries and UDTs could reduce unscheduled hospital admissions due to impaired glucose tolerance. The secondary endpoint was the correlation between the symptoms in the patient diaries and UDT results.ResultsA total of 112 patients were enrolled in the study. Out of the 3197 planned self-UDTs, 3128 (97.8%) were performed. Forty-four patients (39.3%) were admitted to the hospital, two (1.8%) of whom were admitted due to abnormal glucose tolerance, with one having a positive UDT. There were 46 unscheduled outpatient visits (41.1%), of which five (4.5%) were due to abnormal glucose tolerance symptoms and four were due to a positive UDT. The correlation between descriptions of fatigue or dry mouth in the patient diaries and positive glucose UDTs was 52.4% in sensitivity and 62.4% in specificity.ConclusionSelf-monitoring of symptoms and self-performing of UDTs could not reduce the emergency hospitalization rate. However, this approach could be effective in the objective monitoring of patient status, especially regarding glucose intolerance occurrences.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors
    Jessica Castrillon Lal
    Sherry-Ann Brown
    Patrick Collier
    Feixiong Cheng
    Cardio-Oncology, 7
  • [32] Ocular adverse events associated with immune checkpoint inhibitors, a scoping review
    Martens, A.
    Schauwvlieghe, P. P.
    Madoe, A.
    Casteels, I.
    Aspeslagh, S.
    JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION, 2023, 13 (01)
  • [33] Peripheral nervous system adverse events associated with immune checkpoint inhibitors
    Simone Rossi
    Francesco Gelsomino
    Rita Rinaldi
    Lorenzo Muccioli
    Francesca Comito
    Alessandro Di Federico
    Andrea De Giglio
    Giuseppe Lamberti
    Elisa Andrini
    Veronica Mollica
    Roberto D’Angelo
    Flavia Baccari
    Corrado Zenesini
    Pierandrea Madia
    Emanuel Raschi
    Pietro Cortelli
    Andrea Ardizzoni
    Maria Guarino
    Journal of Neurology, 2023, 270 : 2975 - 2986
  • [34] A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors
    Lal, Jessica Castrillon
    Brown, Sherry-Ann
    Collier, Patrick
    Cheng, Feixiong
    CARDIO-ONCOLOGY, 2021, 7 (01)
  • [35] Cutaneous Adverse Events Associated with Immune Checkpoint Inhibitors: A Review Article
    Chen, Chieh-Hsun
    Yu, Hsin-Su
    Yu, Sebastian
    CURRENT ONCOLOGY, 2022, 29 (04) : 2871 - 2886
  • [36] Endocrine adverse events of immune checkpoint inhibitors
    Merlen, E.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2023, 27 (4-5): : 128 - 131
  • [37] Adverse events induced by immune checkpoint inhibitors
    Perdigoto, Ana Luisa
    Kluger, Harriet
    Herold, Kevan C.
    CURRENT OPINION IN IMMUNOLOGY, 2021, 69 : 29 - 38
  • [38] Mucocutaneous adverse events to immune checkpoint inhibitors
    Muhaj, Fiorinda
    Karri, Padmavathi V.
    Moody, Wylie
    Brown, Alexandria
    Patel, Anisha B.
    FRONTIERS IN ALLERGY, 2023, 4
  • [40] Ocular adverse events with immune checkpoint inhibitors
    Fang, Tony
    Maberley, David A.
    Etminan, Mahyar
    JOURNAL OF CURRENT OPHTHALMOLOGY, 2019, 31 (03): : 319 - 322